Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 44,101 | 1,429 | N/A |
| TOTAL | $44,606 | $1,965 | $N/A |
| Non-Current Assets | |||
| PPE Net | 17 | 15 | N/A |
| Investments And Advances | 1,125 | 645 | 0 |
| Other Non-Current Assets | 0 | 25 | 0 |
| TOTAL | $1,142 | $685 | $N/A |
| Total Assets | $45,747 | $2,650 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 3,146 | 404 | 0 |
| Accrued Expenses | N/A | 343 | N/A |
| Other current liabilities | N/A | 5,820 | N/A |
| TOTAL | $4,669 | $22,837 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 49,940 | 0 |
| TOTAL | $N/A | $49,940 | $N/A |
| Total Liabilities | $4,669 | $72,777 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 17,642 | N/A | N/A |
| Common Shares | 18 | 2 | N/A |
| Retained earnings | -90,989 | -70,857 | N/A |
| Other shareholders' equity | 500 | 81 | 0 |
| TOTAL | $41,078 | $-70,127 | $N/A |
| Total Liabilities And Equity | $45,747 | $2,650 | $0 |